Clinical efficacy and safety of patients with functional constipation treated by Mosapride and Sertraline

ZHAO Xiaobo,ZUO Xiuli
DOI: https://doi.org/10.3969/j.issn.1673-7210.2013.04.028
2013-01-01
Abstract:Objective To investigate the clinical efficacy and safety of patients with functional constipation treated by Mosapride and Sertraline.Methods 88 patients with functional constipation who were in the department of gastroenterology in Qilu hospital of Shandong university from June 2008 to June 2012 were collected,they were divided into group A and group B by random number table,with 44 cases in each group.The patients in group A were given Mosapride,while the patients in group B were given Mosapride and Sertraline.Then the clinical efficacy and abverse reactions after treatment for three months of the two groups were compared.Results The total effective rate of group B was significantly higher than group A(95.45% vs 79.55%,P < 0.05).The adverse reaction rates of the two groups were not significant different(P > 0.05).Conclusion The clinical efficacy of Mosapride and Sertraline is superior to patients with functional constipation only by Mosapride.It is safe and reliable and has less adverse reactions.
What problem does this paper attempt to address?